This is a sample. One signal from the Wed, Sep 16, 2026 Rocket scan, frozen with the chart and AI outlook subscribers saw that day. Subscribers get the full list from every scan run, every chart, and a fresh outlook per signal.
Get Full Access →Signal dashboard Sample
AI analysis
Generated for the Wed, Sep 16, 2026 scanA BlastOff (+1) print here says TPST has begun outperforming both the broad market and the biotech group off a low base, which in small-cap clinical names usually reflects accumulation ahead of or in reaction to a catalyst rather than broad sector lift. For the next two weeks the setup implies continuation while the relative-strength line keeps rising, but the signal is early-stage by definition and needs price confirmation rather than assumption.
At $1.21 the scan implies price has pushed above its 21-day average and is attempting to reclaim or extend past the 50-day; confirm which side of each average the last close sits on before treating this as a trend setup versus a bounce. The key tell is volume - a BlastOff in a name this size is only credible if the up days are running well above the 20-day average volume, not on thin prints. A close above roughly $1.32 on expanding volume is the trigger; below that, $1.21 is still inside noise.
A confirmed break and hold above $1.32 opens a move toward $1.45-$1.52 (roughly 20-25% above the signal price) inside two weeks, which requires sustained above-average volume and no fade back under the 21-day average.
Failure to clear $1.32, or a volume-less drift, likely sends price back to $1.09 and then $1.02 (roughly 10-16% below the signal price), driven by profit-taking from whatever move produced the relative-strength reading in the first place.
Sample from a past scan. Not a current signal and not a recommendation to buy or sell.